IVX-0142

· Teva Branded Pharmaceutical Products R&D, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IVX-0142, covering 2021-11-12 to 2021-11-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma [Phase 2]